|
ZNF322A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.004000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.120750E-01 |
| Normal-vs-Stage2 |
5.659400E-01 |
| Normal-vs-Stage3 |
8.182000E-01 |
| Normal-vs-Stage4 |
5.603200E-01 |
| Stage1-vs-Stage2 |
7.090000E-01 |
| Stage1-vs-Stage3 |
5.025900E-02 |
| Stage1-vs-Stage4 |
4.241200E-01 |
| Stage2-vs-Stage3 |
4.548600E-01 |
| Stage2-vs-Stage4 |
8.737800E-01 |
| Stage3-vs-Stage4 |
3.871800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.518400E-01 |
| Normal-vs-AfricanAmerican |
4.054600E-01 |
| Normal-vs-Asian |
1.138410E-01 |
| Caucasian-vs-AfricanAmerican |
8.481400E-01 |
| Caucasian-vs-Asian |
2.884600E-01 |
| AfricanAmerican-vs-Asian |
3.039600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.137400E-01 |
| Normal-vs-Female |
8.427600E-02 |
| Male-vs-Female |
1.012210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.832400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.959600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.318400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.202000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.966000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.555400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.451800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.288160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.170030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.905000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.904800E-03 |
| Normal-vs-Grade 2 |
1.751820E-02 |
| Normal-vs-Grade 3 |
9.120800E-01 |
| Normal-vs-Grade 4 |
5.102400E-02 |
| Grade 1-vs-Grade 2 |
1.512810E-01 |
| Grade 1-vs-Grade 3 |
2.283300E-03 |
| Grade 1-vs-Grade 4 |
1.990280E-04 |
| Grade 2-vs-Grade 3 |
3.736200E-03 |
| Grade 2-vs-Grade 4 |
1.74845999999507E-05 |
| Grade 3-vs-Grade 4 |
1.272200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.863520E-03 |
| Normal-vs-ccB subtype |
2.643600E-01 |
| ccA subtype-vs-ccB subtype |
8.98270000049273E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.688230E-01 |
| Normal-vs-N1 |
4.280000E-01 |
| N0-vs-N1 |
1.838550E-01 |
|
|
